Prosecution Insights
Last updated: November 06, 2026

Windber Research Institute

Technology area: Biotechnology & Pharmaceuticals

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Analysis

Windber Research Institute has 3 pending office actions in Biotechnology & Pharmaceuticals. Each matter is assigned to a separate examiner and art unit, giving the portfolio a distributed prosecution structure.

FRITCHMAN, REBECCA M is the busiest examiner, with 1 pending matter. Since the reported matters are spread across examination channels, counsel should maintain a common technical record while preparing individualized responses.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
1
Medium (33%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (33%)
§112 only1 (33%)
Double-patenting + other1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOWARD, ZACHARY C 1 64.0% +37.8%
FRITCHMAN, REBECCA M 1 45.4% +35.5%
GRAY, JESSICA 1 0.0% +0.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18286075 PROTEIN MARKERS FOR THE PROGNOSIS OF BREAST CANCER PROGRESSION FRITCHMAN, REBECCA M —
17714778 PROTEIN MARKERS FOR ESTROGEN RECEPTOR (ER)-POSITIVE-LIKE AND ESTROGEN RECEPTOR (ER)-NEGATIVE-LIKE BREAST CANCER GRAY, JESSICA —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18286073 PROTEIN MARKERS FOR ESTROGEN RECEPTOR (ER)-POSITIVE LUMINAL A (LA)-LIKE AND LUMINAL B1 (LB1)-LIKE BREAST CANCER HOWARD, ZACHARY C —
18286075 PROTEIN MARKERS FOR THE PROGNOSIS OF BREAST CANCER PROGRESSION FRITCHMAN, REBECCA M —

Top Art Units

Art UnitApps
1674 1
1645 1
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18286073 PROTEIN MARKERS FOR ESTROGEN RECEPTOR (ER)-POSITIVE LUMINAL A (LA)-LIKE AND LUMINAL B1 (LB1)-LIKE BREAST CANCER HOWARD, ZACHARY C 1674 §112 Non-Final OA — Pending Oct 06, 2023
18286075 PROTEIN MARKERS FOR THE PROGNOSIS OF BREAST CANCER PROGRESSION FRITCHMAN, REBECCA M 1645 §101§103§112 Non-Final OA — Pending Oct 06, 2023
17714778 PROTEIN MARKERS FOR ESTROGEN RECEPTOR (ER)-POSITIVE-LIKE AND ESTROGEN RECEPTOR (ER)-NEGATIVE-LIKE BREAST CANCER GRAY, JESSICA 1682 §103DP Final Rejection — Pending Apr 06, 2022

Managing Windber Research Institute's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Windber Research Institute have?

Windber Research Institute has 3 pending office actions as of November 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most Windber Research Institute applications?

Zachary C Howard has the most, with 1 of Windber Research Institute's pending office actions.

What technology area are Windber Research Institute's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month